About MRSA testing
MRSA has been a major cause of concern due to the long-term use of antibiotics, which is now deemed as unnecessary. The inappropriate use of antibiotics may contribute to the rise in drug-resistant bacteria because they do not destroy the bacteria completely. This has been one of the major factors influencing the use of MRSA testing in the medical industry. With this, there is focus on the development of rapid MRSA testing products with greater sensitivity for detection.
Technavio’s analysts forecast the global MRSA testing market to grow at a CAGR of 11.09% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global MRSA testing market for 2017-2021. To calculate the market size, the report considers the new installations/sales/value of MRSA testing products.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global MRSA Testing Market 2017-2021
Technavio recognizes the following companies as the key players in the global MRSA testing market: Becton Dickinson, bioMérieux, and Roche Diagnostics.
Other Prominent Vendors in the market are: Other prominent vendors in the market include 3M, Abacus Diagnostica, AdvanDX, Alere, Arlington Scientific, Atlas Genetics, Bio-Rad Laboratories, Cepheid, Diatherix Laboratories, DxNA, Hain Lifescience, Luminex, Puritan Medical, and R-Biopharm.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is increase in rapid tests for precise testing and superbug detection. Staph infections are the most common hospital acquired infections. The increasing adoption of implantable biomaterials and medical devices, is leading to the increase in infections especially MRSA. The rapid identification and differentiation of MRSA bacteria is important to optimize on treatment decisions. This optimization significantly impacts patient outcomes and cost of care.”
According to the report, one of the major drivers for this market is Growing demand for POC diagnostics in MRSA testing. The growing demand for POC tests for the diagnosis of MRSA is expected to fuel the market growth; POC tests have the potential to improve the management of HA-MRSA and CA-MRSA. These tests provide rapid results, allowing for effective initiation of required treatment. Most importantly, POC tests are simple and can be used at the primary care level and in remote settings without requiring laboratory infrastructure.
Further, the report states that one of the major factors hindering the growth of this market is High cost of MRSA testing procedures. Targeted MRSA screening and infection management using blood sample and nasal swab culture test, POC, and PCR technologies are high in cost.
Becton Dickinson, bioMérieux, Roche Diagnostics, Other prominent vendors in the market include 3M, Abacus Diagnostica, AdvanDX, Alere, Arlington Scientific, Atlas Genetics, Bio-Rad Laboratories, Cepheid, Diatherix Laboratories, DxNA, Hain Lifescience, Luminex, Puritan Medical, R-Biopharm.